David Cuthbertson
David Cuthbertson is an expert in Endocrinology at University of South Florida (United States). As of October 2026, ScienceLeadR ranks David Cuthbertson in the top 1% of experts worldwide for Autoimmune Diseases, Diabetes Mellitus and Glucose Metabolism Disorders. David Cuthbertson has authored 263 publications, the most recent in 2026, and is an investigator in 11 clinical trials. SLR score: 600 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Rheumatology - Immunology - Internal Medicine
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2013 - 2026
Number : 263
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Coxsackievirus B Infections Are Associated With the Risk of Islet Autoimmunity in Children With Strong Genetic Susceptibility to Type 1 Diabetes-Results From the TRIGR Divia Study. PMID 42522919 — diabetes mellitus, autoantibodies, serology, antibodies, genetic predisposition to disease, viruses, diabetes mellitus, type 1, enterovirus, infections, child, virus diseases, autoimmunity | Diabetes Metab Res Rev | 2026 | 0 |
| BMI Normalization Is Associated With Lower Risk of Progression to Type 1 Diabetes, Primarily in Youth. PMID 42461847 — diabetes mellitus, insulin, obesity, overweight, diabetes mellitus, type 1 | Diabetes Care | 2026 | 1 |
| Extended Follow-up of Type 1 Diabetes Immunotherapy Trial Participants Suggests Benign Side Effect Profile. PMID 42283716 — diabetes mellitus, immunotherapy, therapeutics, diabetes mellitus, type 1, infections | Diabetes Care | 2026 | 0 |
| C-Peptide Provides Critical Contextual Insight Into Elevated Glucose Values During Progression to Type 1 Diabetes. PMID 42060373 — diabetes mellitus, autoantibodies, signs and symptoms, therapeutics, diabetes mellitus, type 1, c-peptide | Diabetes Care | 2026 | 0 |
| Higher complement C4 gene copy number constitutes a shared genetic risk factor for giant cell arteritis and IgA vasculitis. PMID 42045811 — cells, complement c4, genes, vasculitis, arthritis, iga vasculitis, arteritis, rheumatic diseases, giant cells, alleles, sex, risk factors, complement system proteins, giant cell arteritis, gene dosage | Arthritis Rheumatol | 2026 | 0 |
Clinical Studies 11
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 17
LeadR Networks
Main global connection map